These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2017 Archives

Jun 20, 2017
Immune's subsidiary, CYTOVIA, to implement development and commercialization plan for Ceplene
Jun 19, 2017
Jun 15, 2017
Immune's subsidiary, Cytovia, plans commercialization activities in Europe and Latin America
May 26, 2017
May 4, 2017
Apr 24, 2017
- Inflammatory disease and dermatology business to become the focus of Immune Pharmaceuticals, Inc., with specific emphasis on bertilimumab and NanoCyclo products
Apr 24, 2017
Apr 20, 2017
Apr 12, 2017
Mar 13, 2017
Feb 28, 2017
Broadens Eligibility Criteria to Include Steroid Tapering Resistant Patients
Feb 17, 2017
Ceplene Currently Approved in Europe and Israel
Jan 27, 2017
Ranch Kimball to Lead Immune's Board of Directors
Jan 23, 2017
Jan 17, 2017
"Reinforcing the Efficacy of Immunotherapy for the maintenance of remission in AML with Ceplene®", February 20, 2017
Jan 9, 2017
 

print email rss